IMMUNOGENETICS OF HUMAN AMERICAN CUTANEOUS LEISHMANIASIS - STUDY OF HLA HAPLOTYPES IN 24 FAMILIES FROM VENEZUELA

被引:46
作者
LARA, ML
LAYRISSE, Z
SCORZA, JV
GARCIA, E
STOIKOW, Z
GRANADOS, J
BIAS, W
机构
[1] INST VENEZOLANO INVEST CIENT,CTR MED EXPTL,APARTADO 21827,CARACAS 1020A,VENEZUELA
[2] UNIV LOS ANDES,CTR INVEST TRUJILLANAS,MERIDA,VENEZUELA
[3] INST NACL NUTR SALVADOR ZUBIRAN,DEPT INMUNOL,MEXICO CITY 14000,DF,MEXICO
[4] JOHNS HOPKINS UNIV,SCH MED,IMMUNOGENET LABS,BALTIMORE,MD 21205
关键词
D O I
10.1016/0198-8859(91)90081-J
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Twenty-four families with one or multiple cases of localized cutaneous leishmaniasis (LCL) from an endemic region with the highest incidence of LCL in Venezuela were typed from HLA-ABC, DR, DQ antigens and complement factors. The parental HLA haplotypes segregated at random among healthy and affected siblings but in backcross families significantly higher frequencies of HLA-A28 (p = 0.0018), -Bw22 (p = 0.0122), or -DQw8 (p = 0.0364) were present in affected compared to healthy siblings. HLA-B15 showed a higher frequency (p = 0.0062) among the latter group. Haplotypes Bw22CF31 (p = 0.0076) and Bw22DRw11DQw7 (p = 0.0163) were also significantly more frequent in affected compared to healthy siblings and A2Cw- (p = 0.0445) among the latter. No HLA genetic linkage with a putative LCL susceptibility gene(s) could be demonstrated in this study. A case/control comparison of 26 unrelated LCL patients (one proband from each family) and healthy individuals of the same ethnic origin confirmed the association of HLA-Bw22 (p(c) = 0.048) and -DQw3 (p(c) = 0.036) with LCL. The relative risk reached 12.5 for Bw22 and 4.25 for DQw3 with ethiologic factors of 0.17 and 0.64, respectively. HLA-DQw3 apparently makes the major contribution as a genetic risk factor for LCL at the population level.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 22 条
[1]   RESPONSIVENESS IN DIFFUSE VERSUS LOCAL CUTANEOUS LEISHMANIASIS IS DUE TO PARASITE DIFFERENCES [J].
AKUFFO, JH ;
SCHURR, E ;
ANDERSSON, G ;
YAMANEBERHAN, T .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 26 (06) :717-721
[2]  
BARBIER D, 1987, TISSUE ANTIGENS, V30, P63, DOI 10.1111/j.1399-0039.1987.tb01598.x
[3]  
BAUR MP, 1984, HISTOCOMPATIBILITY T, P677
[4]  
BLACKWELL J, 1980, NATURE, V283, P72, DOI 10.1038/283072a0
[5]  
Blackwell J., 1986, Parasitology Today, V2, P45
[6]  
Bodmer W. F., 1971, GENETICS HUMAN POPUL
[7]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[8]   GENETIC-CONTROL OF NATURAL RESISTANCE TO LEISHMANIA-DONOVANI [J].
BRADLEY, DJ .
NATURE, 1974, 250 (5464) :353-353
[9]  
BRYCESON AD, 1970, T ROY SOC TROP MED H, V64, P387
[10]  
CASTES M, 1984, CLIN EXP IMMUNOL, V57, P279